-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Hempacco (NASDAQ:HPCO) Vs. 22nd Century Group (NASDAQ:XXII) Head to Head Review
Hempacco (NASDAQ:HPCO) Vs. 22nd Century Group (NASDAQ:XXII) Head to Head Review
Hempacco (NASDAQ:HPCO – Get Rating) and 22nd Century Group (NASDAQ:XXII – Get Rating) are both small-cap consumer discretionary companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, dividends, valuation and earnings.
Earnings & Valuation
This table compares Hempacco and 22nd Century Group's gross revenue, earnings per share and valuation.
Get Hempacco alerts:Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Hempacco | N/A | N/A | N/A | N/A | N/A |
22nd Century Group | $30.95 million | 6.54 | -$32.61 million | ($0.26) | -3.63 |
Hempacco has higher earnings, but lower revenue than 22nd Century Group.
Analyst Recommendations
This is a breakdown of recent recommendations for Hempacco and 22nd Century Group, as reported by MarketBeat.Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Hempacco | 0 | 0 | 0 | 0 | N/A |
22nd Century Group | 0 | 0 | 4 | 0 | 3.00 |
22nd Century Group has a consensus target price of $6.13, suggesting a potential upside of 549.66%. Given 22nd Century Group's higher possible upside, analysts plainly believe 22nd Century Group is more favorable than Hempacco.
Profitability
This table compares Hempacco and 22nd Century Group's net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Hempacco | N/A | N/A | N/A |
22nd Century Group | -111.52% | -51.39% | -44.63% |
Institutional & Insider Ownership
19.8% of 22nd Century Group shares are held by institutional investors. 2.4% of 22nd Century Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Summary
22nd Century Group beats Hempacco on 5 of the 8 factors compared between the two stocks.
About Hempacco
(Get Rating)
Hempacco Co., Inc. manufactures and sells smokable hemp and herb products in California. It offers The Real Stuff hemp smokables. The company was formerly known as The Hempacco Co., Inc. and changed its name to Hempacco Co., Inc. in May 2021. The company was incorporated in 2019 and is headquartered in San Diego, California. Hempacco Co., Inc. operates as a subsidiary of Green Globe International, Inc.
About 22nd Century Group
(Get Rating)
22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.
Receive News & Ratings for Hempacco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hempacco and related companies with MarketBeat.com's FREE daily email newsletter.
Hempacco (NASDAQ:HPCO – Get Rating) and 22nd Century Group (NASDAQ:XXII – Get Rating) are both small-cap consumer discretionary companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, dividends, valuation and earnings.
亨普科(納斯達克:HPCO-GET評級)和22世紀集團(納斯達克:XXII-GET評級)都是小型非必需消費品公司,但哪隻股票更好?我們將根據這兩家公司的風險、盈利能力、分析師建議、機構持股、股息、估值和收益的強弱對它們進行比較。
Earnings & Valuation
收益與估值
This table compares Hempacco and 22nd Century Group's gross revenue, earnings per share and valuation.
此表比較了漢普科和22世紀集團的毛收入、每股收益和估值。
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Hempacco | N/A | N/A | N/A | N/A | N/A |
22nd Century Group | $30.95 million | 6.54 | -$32.61 million | ($0.26) | -3.63 |
總收入 | 價格/銷售額比 | 淨收入 | 每股收益 | 市盈率 | |
漢普科 | 不適用 | 不適用 | 不適用 | 不適用 | 不適用 |
22世紀集團 | 3095萬美元 | 6.54 | -3,261萬元 | ($0.26) | -3.63 |
Hempacco has higher earnings, but lower revenue than 22nd Century Group.
漢普科的收益高於22世紀集團,但營收低於22世紀集團。
Analyst Recommendations
分析師建議
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Hempacco | 0 | 0 | 0 | 0 | N/A |
22nd Century Group | 0 | 0 | 4 | 0 | 3.00 |
銷售評級 | 保持評級 | 購買評級 | 強勁的買入評級 | 評級分數 | |
漢普科 | 0 | 0 | 0 | 0 | 不適用 |
22世紀集團 | 0 | 0 | 4 | 0 | 3.00 |
22nd Century Group has a consensus target price of $6.13, suggesting a potential upside of 549.66%. Given 22nd Century Group's higher possible upside, analysts plainly believe 22nd Century Group is more favorable than Hempacco.
22世紀集團的普遍目標價為6.13美元,暗示潛在上漲549.66%。考慮到22世紀集團更有可能的上行空間,分析師們顯然認為22世紀集團比漢普科更有利。
Profitability
盈利能力
This table compares Hempacco and 22nd Century Group's net margins, return on equity and return on assets.
此表比較了漢普科和22世紀集團的淨利潤率、股本回報率和資產回報率。
Net Margins | Return on Equity | Return on Assets | |
Hempacco | N/A | N/A | N/A |
22nd Century Group | -111.52% | -51.39% | -44.63% |
淨利潤率 | 股本回報率 | 資產回報率 | |
漢普科 | 不適用 | 不適用 | 不適用 |
22世紀集團 | -111.52% | -51.39% | -44.63% |
Institutional & Insider Ownership
機構與內部人持股
19.8% of 22nd Century Group shares are held by institutional investors. 2.4% of 22nd Century Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
22世紀集團19.8%的股份由機構投資者持有。22世紀集團2.4%的股份由內部人士持有。強大的機構持股表明,對衝基金、大型基金管理公司和捐贈基金相信,一隻股票有望實現長期增長。
Summary
摘要
22nd Century Group beats Hempacco on 5 of the 8 factors compared between the two stocks.
22世紀集團在兩隻股票比較的8個因素中有5個擊敗了漢普科。
About Hempacco
關於漢普科
(Get Rating)
(獲取評級)
Hempacco Co., Inc. manufactures and sells smokable hemp and herb products in California. It offers The Real Stuff hemp smokables. The company was formerly known as The Hempacco Co., Inc. and changed its name to Hempacco Co., Inc. in May 2021. The company was incorporated in 2019 and is headquartered in San Diego, California. Hempacco Co., Inc. operates as a subsidiary of Green Globe International, Inc.
漢普科公司在加利福尼亞州製造和銷售可煙燻大麻和草藥產品。它提供真正的大麻煙薰製品。該公司前身為漢普科公司,並於2021年5月更名為漢普科公司。該公司成立於2019年,總部位於加利福尼亞州聖地亞哥。漢普科公司是綠色環球國際公司的子公司。
About 22nd Century Group
關於22世紀集團
(Get Rating)
(獲取評級)
22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.
22世紀集團公司是一家農業生物技術公司,專注於減少煙草危害,減少尼古丁煙草,並通過植物科學為生命科學和消費品行業提高健康和健康。該公司開發尼古丁含量極低的煙草和捲煙產品,並以VLN King和VLN薄荷醇王的名稱命名;以及用於獨立臨牀研究的光譜研究香煙。該公司與Keygene N.V.合作開發大麻/大麻植物,用於特殊的大麻素特徵和其他用於醫療、治療和農業以及其他應用的優良農藝性狀。22世紀集團成立於1998年,總部設在紐約布法羅。
Receive News & Ratings for Hempacco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hempacco and related companies with MarketBeat.com's FREE daily email newsletter.
接受《漢普科日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對漢普科和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧